Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

28.5K
Overview
28.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

431
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
431
Allergic Drug Reactions01:27

Allergic Drug Reactions

965
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
965
Cross-reactivity00:42

Cross-reactivity

31.5K
Overview
31.5K
Hypersensitivities01:30

Hypersensitivities

1.0K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
1.0K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Food allergy, biologic therapies, and diagnostic precision: Expanding frontiers in allergy and immunology.

Allergy and asthma proceedings·2026
Same author

Touchstones of compassionate care in allergy-immunology beyond artificial intelligence: Connection and generational legacy.

The journal of allergy and clinical immunology. In practice·2026
Same author

From molecular pathways to meaningful patient management: Navigating complexity in allergy and immunology.

Allergy and asthma proceedings·2026
Same author

Across the arc of allergy: From maternal immune tolerance to food sensitization pathways and lifesaving anaphylaxis care.

Allergy and asthma proceedings·2026
Same author

Group Learning, Shared Decisions, Compassionomics, and the Fountain of Youth.

The journal of allergy and clinical immunology. In practice·2026
Same author

Evolving therapies for chronic spontaneous urticaria: Addressing unmet needs in adults and children.

Allergy and asthma proceedings·2025

Related Experiment Video

Updated: Sep 5, 2025

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.5K

Allergen immunotherapy and shared decision-making.

Russell A Settipane, Don A Bukstein

    Allergy and Asthma Proceedings
    |July 12, 2022
    PubMed
    Summary
    This summary is machine-generated.

    Shared decision-making (SDM) can improve allergic rhinoconjunctivitis management. This article explores using SDM aids to enhance patient and practitioner collaboration for effective treatment, including allergen immunotherapy (AIT).

    More Related Videos

    Humanized Mediator Release Assay as a Read-Out for Allergen Potency
    10:22

    Humanized Mediator Release Assay as a Read-Out for Allergen Potency

    Published on: June 29, 2021

    3.6K
    Basophil Activation Test for Allergy Diagnosis
    07:22

    Basophil Activation Test for Allergy Diagnosis

    Published on: May 31, 2021

    8.5K

    Related Experiment Videos

    Last Updated: Sep 5, 2025

    Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
    08:47

    Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

    Published on: March 3, 2023

    2.5K
    Humanized Mediator Release Assay as a Read-Out for Allergen Potency
    10:22

    Humanized Mediator Release Assay as a Read-Out for Allergen Potency

    Published on: June 29, 2021

    3.6K
    Basophil Activation Test for Allergy Diagnosis
    07:22

    Basophil Activation Test for Allergy Diagnosis

    Published on: May 31, 2021

    8.5K

    Area of Science:

    • Allergy and Immunology
    • Clinical Decision-Making
    • Health Informatics

    Background:

    • Allergic rhinoconjunctivitis management is complex due to numerous treatment options and disease progression risks.
    • A gap exists in tools facilitating shared decision-making (SDM) between patients and practitioners.
    • Patient preferences are crucial for optimizing treatment strategies.

    Purpose of the Study:

    • To review the principles of SDM in allergic rhinoconjunctivitis.
    • To highlight the need for and utility of SDM aids, particularly for allergen immunotherapy (AIT).
    • To provide actionable steps for implementing AIT-focused SDM in clinical practice.

    Main Methods:

    • Literature review on SDM constructs and tools.
    • Analysis of patient preference data collection methods.
    • Evaluation of existing SDM aids for AIT.
    • Outline of practical implementation strategies for SDM in AIT.

    Main Results:

    • SDM offers a structured approach to navigate complex treatment choices in allergic rhinoconjunctivitis.
    • Specific SDM aids can enhance patient engagement and shared decision-making for AIT.
    • Patient preference data collection is vital for personalized management.

    Conclusions:

    • Implementing SDM, supported by appropriate aids, can optimize allergic rhinoconjunctivitis management.
    • Facilitating patient-practitioner collaboration through SDM is key for effective AIT decisions.
    • Actionable steps are outlined to integrate SDM into routine clinical practice for AIT.